Dermatomyositis‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development
Abstract COVID‐19 should be considered as a new triggering factor for autoimmune disorders like DM‐lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID‐19.
Guardado en:
Autores principales: | Mohammad Shahidi Dadras, Azadeh Rakhshan, Arman Ahmadzadeh, Seyed Ali Hosseini, Reem Diab, Toktam Safari Giv, Fahimeh Abdollahimajd |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e356d883bbcc4adb9951d5b0c93059f0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Manifestaciones clínicas y anticuerpos asociados y específicos de miositis en 15 pacientes chilenos con dermatomiositis: serie clínica en un centro universitario
por: Maraví T.,Zósimo, et al.
Publicado: (2020) -
Miopatías inflamatorias idiopáticas: una mirada actualizada al diagnóstico y el manejo
por: Acosta,Ignacio, et al.
Publicado: (2019) -
Performance of ENMC and EULAR/ACR classification systems applied to a single tertiary center cohort of dermatomyositis patients
por: Jan Zoske, et al.
Publicado: (2021) -
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
por: Abhinav K. Misra, et al.
Publicado: (2021) -
Wong-Type Dermatomyositis: An Extremely Rare Disease in Childhood
por: Mario Diplomatico, et al.
Publicado: (2019)